• Most Popular
  • Most Shared

Lawmakers question Vytorin cancer risk data

WASHINGTON
Thu Aug 21, 2008 12:26pm EDT

WASHINGTON (Reuters) - Two top Democratic lawmakers on Thursday questioned recent claims by Merck & Co Inc and Schering Plough Corp that incidents of cancer in patients taking their cholesterol drug Vytorin were a fluke.

U.S.  |  Barack Obama  |  Health  |  Stocks  |  Regulatory News

The lawmakers, Rep. John Dingell and Rep. Bart Stupak, both from Michigan, are seeking 10 years of related company records after a study last month found Vytorin patients had a higher rate of cancer than those taking a placebo.

(Reporting by Susan Heavey; editing by John Wallace)
U.S.
Barack Obama
Health
Stocks
Regulatory News


More from Reuters

Photo

Fox, Time Warner Cable ink temp deal to avoid blackout

NEW YORK (Reuters) - Time Warner Cable and News Corp's Fox Networks agreed to a brief extension of their current carriage contract on Thursday to avoid a blackout that would have prevented 13 million U.S. homes from seeing TV shows like "The Simpsons" and college and NFL football games.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Clients work out on machines at the Bally Total Fitness facility in Arvada, Colorado June 15, 2009. REUTERS/Rick Wilking

Get real with resolutions

We make them and we break them: The secret to keeping them is to avoid the impossible dream.  Full Article 

Lifestyle